A carregar...
Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician’s perspective
OBJECTIVE: In this review, we have summarized the pharmacokinetics, pharmacodynamics and adverse effects of imatinib, dasatinib, nilotinib, bosutinib, ponatinib and radotinib with focus on pharmacogenomic studies with clinical end points. We have discussed the key phase 3 trials of tyrosine kinase i...
Na minha lista:
| Publicado no: | Daru |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214547/ https://ncbi.nlm.nih.gov/pubmed/31900888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40199-019-00321-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|